Fulcrum Therapeutics (NASDAQ:FULC) investors are sitting on a loss of 60% if they invested five years ago

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) has seen a 136% increase in the last quarter, but long-term investors have suffered a 60% loss.